22Nd Century Group (XXII) closed at $1.55 on November 6, 2026, down 19.7% from the previous close, on volume of 167,555 shares (30-day average 34,084,185).
Data as of November 6, 2026.
22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026
Globe Newswire (Tue, 3-Nov 4:03 PM ET)
22nd Century Announces 1-for-58 Reverse Stock Split
TipRanks (Tue, 3-Nov 11:57 AM ET)
22nd Century Signs Groundbreaking Agreement with Gopuff
Globe Newswire (Thu, 29-Oct 4:30 PM ET)
Globe Newswire (Wed, 28-Oct 4:36 PM ET)
XXII Expands Pinnacle Pure to 6 SKUs as 100’s and Menthol Target Half of the U.S. Cigarette Market
Market Chameleon (Tue, 27-Oct 5:54 AM ET)
Globe Newswire (Mon, 26-Oct 7:37 AM ET)
Oil Above $100 Puts Penny Stocks in Focus
Globe Newswire (Fri, 23-Oct 11:59 AM ET)
Market Chameleon (Thu, 22-Oct 6:58 AM ET)
22nd Century Group Preliminarily Reports Third Quarter Financial Results
Globe Newswire (Thu, 22-Oct 10:35 AM ET)
22nd Century Same Store Unit Sales for Pinnacle VLN and Pinnacle Pure Surge 161%
Globe Newswire (Thu, 15-Oct 4:30 PM ET)
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.
22Nd Century Group trades on the NASDAQ stock market under the symbol XXII.
As of November 6, 2026, XXII stock price declined to $1.55 with 167,555 million shares trading.
XXII has a beta of 5.05, meaning it tends to be more sensitive to market movements. XXII has a correlation of 0.04 to the broad based SPY ETF.
XXII has a market cap of $853,828.00. This is considered a Sub-Micro Cap stock.
Last quarter 22Nd Century Group reported $3 million in Revenue and -$15.60 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$15.30.
In the last 3 years, XXII traded as high as $26,718,340.00 and as low as $1.51.
XXII has underperformed the market in the last year with a price return of -99.9% while the SPY ETF gained +10.8%. XXII has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -99.4% and -86.5%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
XXII support price is $1.52 and resistance is $2.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XXII shares will trade within this expected range on the day.